Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Foot massage machine tested for Parkinson's: could it boost mobility?

NCT ID NCT04251728

Symptom relief Sponsor: Universidad Católica del Maule Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding a device that applies pressure to specific points on the feet (automated mechanical peripheral stimulation, or AMPS) to a regular exercise program could improve heart health and movement in people with Parkinson's disease. Forty participants were split into two groups: one received real AMPS plus exercise, the other a fake (sham) device plus exercise. Researchers measured physical function, aerobic capacity, quality of life, and motor symptoms over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Automated mechanical peripheral stimulation (AMPS) device
What this could lead to
If it works, this could point toward a simple, drug-free way to improve mobility and heart health in people with Parkinson's disease.
What could go wrong
This is a small, early-stage study with only 40 participants. The results may not apply to everyone with Parkinson's, and the device might not provide significant benefits over exercise alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Mar 2022

Finished

Dec 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinical diagnosis of idiopathic Parkinson's disease * Scoring 1 to 3 on the Hoehn and Yhar scale * Pharmacological treatment unchanged for at least 30 days prior the study Exclusion Criteria: * Signs of cognitive decline, based on the results of the Mini Mental State Examination * Cardiorespiratory, neuromuscular and musculoskeletal diseases not related to PD * Sensory peripheral neuropathy, diabetes or any other disease known to promote autonomic dysfunction * Changes in pharmacological treatment after inclusion in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson disease

Contacts and locations

Locations

  • Universidad Católica del Maule

    Talca, Maule Region, 3469001, Chile

More trials for these conditions

Other studies related to the condition(s) this trial covers.